Long-Term Evolution of Metabolic Status in Patients with Schizophrenia Stably Maintained on Second-Generation Antipsychotics
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-Term Evolution of Metabolic Status in Patients with Schizophrenia Stably Maintained on Second-Generation Antipsychotics
Authors
Keywords
-
Journal
Psychiatry Investigation
Volume 15, Issue 6, Pages 628-637
Publisher
Korean Neuropsychiatric Association
Online
2018-06-21
DOI
10.30773/pi.2018.01.18.1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome
- (2016) Jorge Zimbron et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Mean arterial pressure values calculated using seven different methods and their associations with target organ deterioration in a single-center study of 1878 individuals
- (2016) Theodore G Papaioannou et al. HYPERTENSION RESEARCH
- The Natural History of Patients With Isolated Metabolic Syndrome
- (2016) Pratik A. Patel et al. MAYO CLINIC PROCEEDINGS
- Treatment of clozapine-associated weight gain: a systematic review
- (2015) Z. Whitney et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis
- (2015) Davy Vancampfort et al. World Psychiatry
- Metabolic issues in patients affected by schizophrenia: clinical characteristics and medical management
- (2015) Antonio Ventriglio et al. Frontiers in Neuroscience
- Data Resource Profile: The Korea National Health and Nutrition Examination Survey (KNHANES)
- (2014) S. Kweon et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- A Naturalistic Comparison of the Long-Term Metabolic Adverse Effects of Clozapine Versus Other Antipsychotics for Patients With Psychotic Illnesses
- (2014) Anne C. Kelly et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Can Exercise Increase Fitness and Reduce Weight in Patients with Schizophrenia and Depression?
- (2014) Jesper Krogh et al. Frontiers in Psychiatry
- Cardiometabolic comorbidity in antipsychotic treated patients: need for systematic evaluation and treatment
- (2013) Pauline M. J. Steylen et al. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
- A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls
- (2013) Davy Vancampfort et al. World Psychiatry
- Effectiveness of interventions for reducing diabetes and cardiovascular disease risk in people with metabolic syndrome: systematic review and mixed treatment comparison meta-analysis
- (2012) A. J. Dunkley et al. DIABETES OBESITY & METABOLISM
- The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia
- (2012) N.Y. Lee et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients
- (2012) A. J. Mitchell et al. SCHIZOPHRENIA BULLETIN
- The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone
- (2011) Nam Young Lee et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Prediction of long-term metabolic effects of olanzapine and risperidone treatment from baseline body mass index in schizophrenia and bipolar disorder
- (2011) William Victor Bobo et al. PSYCHIATRY RESEARCH
- Prevalence of Metabolic Syndrome and Metabolic Abnormalities in Schizophrenia and Related Disorders—A Systematic Review and Meta-Analysis
- (2011) Alex J. Mitchell et al. SCHIZOPHRENIA BULLETIN
- Association of Weight Gain and Metabolic Syndrome in Patients Taking Clozapine
- (2010) Ya Mei Bai et al. JOURNAL OF CLINICAL PSYCHIATRY
- Predictive Value of Early Changes in Triglycerides and Weight for Longer-Term Changes in Metabolic Measures During Olanzapine, Ziprasidone or Aripiprazole Treatment for Schizophrenia and Schizoaffective Disorder
- (2010) Vicki P. Hoffmann et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA RESEARCH
- The cutoff values of visceral fat area and waist circumference for identifying subjects at risk for metabolic syndrome in elderly Korean: Ansan Geriatric (AGE) cohort study
- (2009) Ji A Seo et al. BMC PUBLIC HEALTH
- The incidence of metabolic syndrome and its reversal in a cohort of schizophrenic patients followed for one year
- (2009) S.G. Schorr et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Second-generation antipsychotics for schizophrenia: can we resolve the conflict?
- (2009) S. Leucht et al. PSYCHOLOGICAL MEDICINE
- Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review
- (2008) Marc De Hert et al. SCHIZOPHRENIA RESEARCH
- Early treatment-related changes in diabetes and cardiovascular disease risk markers in first episode psychosis subjects
- (2008) Karen A. Graham et al. SCHIZOPHRENIA RESEARCH
- Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1
- (2008) Jonathan M. Meyer et al. SCHIZOPHRENIA RESEARCH
- Metabolic syndrome in first episode schizophrenia — A randomized double-blind controlled, short-term prospective study
- (2008) Sahoo Saddichha et al. SCHIZOPHRENIA RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More